Evaluation of genetic susceptibility between systemic lupus erythematosus and GRB2 gene

Meifeng Xu, Yan Liu, Xiaoli Li, Chuantao Cheng, Yale Liu, Wei Dong, Shaoyi Du, Shengxiang XiaoScientific 2019 · DOI

Abstract

Systemic lupus erythematosus (SLE) is a complex autoimmune disease influenced by both genetic and environmental factors. The GRB2 gene product is a critical factor in B-cell activation and has previously been associated with SLE in European populations. This study aimed to investigate this relationship in a Han Chinese population. By genotyping 20 tagging SNPs in 1,710 Han Chinese women (567 patients and 1,143 controls), we identified a significant association between SNP rs36023980 and SLE risk. The 'T' allele of rs36023980 was found to be protective (OR = 0.61, P = 0.0003). Furthermore, this SNP was linked to complement inhibition in patients and regulated GRB2 expression in whole blood and skin tissues. These findings confirm the role of GRB2 in SLE susceptibility across different ethnic groups.

Introduction

Systemic Lupus Erythematosus (SLE) is characterized by the production of autoantibodies and multi-organ inflammation. While Genome-Wide Association Studies (GWAS) have identified numerous risk loci, the genetic architecture of SLE varies significantly between ethnicities. The GRB2 (Growth Factor Receptor-Bound Protein 2) gene is a key signaling adapter involved in B-cell receptor signaling. Given its role in immune regulation and previous associations in European cohorts, validating its impact in the Han Chinese population—who often experience higher disease prevalence—is a critical step in understanding the global genetic landscape of SLE.

Methods and SNP Selection

The study cohort consisted of 1,710 unrelated Han Chinese women recruited from the Second Affiliated Hospital of Xi’an Jiaotong University. To capture the genetic variation of the GRB2 gene, 20 tagging SNPs were selected based on the 1000-Genomes CHB database. Genotyping was performed using the Sequenom MassARRAY platform.

Linkage disequilibrium (LD) plot of the 20 SNPs in the GRB2 gene region, showing the three primary haplotype blocks identified in the study.

Statistical analyses utilized logistic regression to assess associations, adjusting for age. Additionally, expression quantitative trait loci (eQTL) data from the GTEx database were analyzed to determine the functional impact of significant SNPs on gene expression across various human tissues.

Results

Identification of a Protective Variant

The primary finding of the study was the significant association of SNP rs36023980 with SLE. Both genotypic and allelic tests demonstrated that the 'T' allele serves as a protective factor against the development of the disease. Specifically, the frequency of the T allele was 6.3% in SLE patients compared to 10.2% in healthy controls, resulting in an odds ratio (OR) of 0.61 (P = 0.0003).

Genotypic and allelic association analysis of SNP rs36023980 with SLE risk, highlighting the significant P-values and protective odds ratio.

Clinical and Functional Correlations

Beyond overall risk, the rs36023980 genotype was significantly associated with complement inhibition ($P = 0.003$) in SLE patients. Stratification analysis revealed that the genetic signal was predominantly driven by the subgroup of patients exhibiting complement depression, suggesting that GRB2 may influence the innate immune system's clearance pathways.

Functional eQTL analysis further supported these findings. The risk-associated 'C' allele was correlated with higher expression levels of GRB2 in whole blood ($P = 7.7 \times 10^{-6}$) and sun-exposed skin ($P = 0.0003$). This suggests that increased production of the GRB2 protein may contribute to the hyper-activation of B cells and the subsequent autoimmune response characteristic of SLE.

Discussion and Conclusion

This study successfully validates the GRB2 locus as a susceptibility factor for SLE in the Han Chinese population, mirroring results found in European studies. The identification of rs36023980 as a regulatory variant affecting both gene expression and clinical manifestations like complement inhibition provides a biological bridge between genetic variation and disease pathology.

While the study is limited by its focus on female participants and intronic SNPs, it underscores the importance of GRB2 in the systemic and cutaneous manifestations of lupus. Future research should focus on the exact molecular mechanisms by which these non-coding variants modulate GRB2 expression and explore the potential of this pathway for targeted therapeutic interventions.

Summary updated

Abstract

Multiple lines of evidence have shown that systemic lupus erythematosus (SLE) is attributable to both genetic and environmental factors. The product of GRB2 is a key factor in the activation of B cells and has been reported to be significantly associated with SLE in European populations. In the study, we aimed to investigate the relationship between GRB2 and SLE. A total of 1,710 Han Chinese women comprising 567 SLE patients and 1,143 controls were recruited to genotype 20 selected tagging SNPs. We tested the potential association between 13 clinical variables of SLE and the significant polymorphisms related to SLE. The eQTL data were extracted from the GTEx database to examine the functional consequences of the targeted SNPs. A significant association signal was identified between rs36023980 and SLE in both genotypic and allelic analyses (OR = 0.61, P = 0.0003). Complement inhibition was shown to be significantly associated with the genotypes of SNP rs36023980 in SLE patients (P<sub>genotype</sub> = 0.003). Further stratification analyses showed that the genetic association signal of SNP rs36023980 on SLE could only be identified in cases with complement inhibition. SNP rs36023980 was also identified to be significantly associated with the expression of GRB2 in whole blood and sun-exposed skin. In conclusion, our findings confirm the results from the previous GWAS and are the first to report the association of GRB2 with SLE in Han Chinese population.
BibTeX
@inproceedings{xu2019evaluation,
  author = {Meifeng Xu and Yan Liu and Xiaoli Li and Chuantao Cheng and Yale Liu and Wei Dong and Shaoyi Du and Shengxiang Xiao},
  title = {{Evaluation of genetic susceptibility between systemic lupus erythematosus and GRB2 gene}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-46827-z},
}
Figure